Infantile onset panniculitis with uveitis and systemic granulomatosis: a new clinicopathologic entity

Carine H Wouters1, Tammy M Martin, Dorothee Stichweh

  • 1University Hospital Gasthuisberg, Leuven, Belgium. carine.wouters@uz.kuleuven.ac.be

The Journal of Pediatrics
|November 24, 2007
PubMed

Insights

Four children experienced infantile-onset lobular panniculitis with fever and uveitis. Standard immunosuppressive therapy was ineffective, but anti-tumor necrosis factor monoclonal antibody showed promise in treating this rare inflammatory condition.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Background:

  • Infantile-onset lobular panniculitis is a rare inflammatory condition.
  • Associated symptoms include high fever, uveitis, and systemic granulomatous inflammation.
  • Genetic mutations in CARD15 and CIAS1 are not consistently found in these cases.

Purpose of the Study:

  • To describe the clinical characteristics and treatment outcomes of children with infantile-onset lobular panniculitis.
  • To investigate the genetic basis of this condition.
  • To evaluate the efficacy of different therapeutic strategies.

Main Methods:

  • Case series of 4 children recruited through the International Registry of Pediatric Granulomatous Arthritis.
  • Clinical data collection including symptoms, disease course, and treatment response.
  • Genetic analysis for CARD15 and CIAS1 mutations.

Main Results:

  • All 4 patients presented with infantile-onset lobular panniculitis, high fever, uveitis, and systemic granulomatous inflammation.
  • No mutations in CARD15 or CIAS1 were identified.
  • Disease progression was observed despite conventional immunosuppressive therapy.
  • Three out of four patients showed a positive response to anti-tumor necrosis factor monoclonal antibody treatment.

Conclusions:

  • Infantile-onset lobular panniculitis is a severe condition unresponsive to standard immunosuppression.
  • Genetic testing for CARD15 and CIAS1 may not be informative in all cases.
  • Anti-tumor necrosis factor monoclonal antibody therapy represents a potential treatment option for this challenging pediatric inflammatory disease.

Related Concept Videos

Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...